Researchers initiated a pioneering clinical trial using an advanced form of CAR-T therapy, enhanced by synthetic notch (synNotch) technology, to treat glioblastoma. This trial represents a significant shift towards targeted, safer cancer therapies.
You May Also Like
Tiny Robotic Nerve Cuffs Promise Breakthrough in Neurocare
April 28, 2024
Gene Therapy Slows ALS Progression
April 27, 2024
Spinal Injuries Trigger Metabolic Disorders
April 24, 2024
More From Author
Impulsivity Influences Choices Between Food and Money
April 28, 2024
Tiny Robotic Nerve Cuffs Promise Breakthrough in Neurocare
April 28, 2024
+ There are no comments
Add yours